SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Radu Calin 1969 )
 

Search: WFRF:(Radu Calin 1969 ) > Nordic anal cancer ...

  • Nilsson, Martin P.Lund University,Lunds universitet,Lund Univ, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden.;Skane Univ Hosp, Dept Hematol Oncol & Radiat Phys, Lund, Sweden.,Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Systemisk strålterapi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Systemic radiation therapy,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine (author)

Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer

  • Article/chapterEnglish2023

Publisher, publication year, extent ...

  • Taylor & Francis,2023
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-520216
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-520216URI
  • https://doi.org/10.1080/0284186X.2023.2240490DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-214991URI
  • https://lup.lub.lu.se/record/bc008cde-e78e-4c1c-9394-b89f39b16fc2URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Background: To date, anal cancer patients are treated with radiotherapy to similar volumes despite a marked difference in risk profile based on tumor location and stage. A more individualized approach to delineation of the elective clinical target volume (CTVe) could potentially provide better oncological outcomes as well as improved quality of life. The aim of the present work was to establish Nordic Anal Cancer (NOAC) group guidelines for delineation of the CTVe in anal cancer.Methods: First, 12 radiation oncologists reviewed the literature in one of the following four areas: (1) previous delineation guidelines; (2) patterns of recurrence; (3) anatomical studies; (4) common iliac and para-aortic recurrences and delineation guidelines. Second, areas of controversy were identified and discussed with the aim of reaching consensus.Results: We present consensus-based recommendations for CTVe delineation in anal cancer regarding (a) which regions to include, and (b) how the regions should be delineated. Some of our recommendations deviate from current international guidelines. For instance, the posterolateral part of the inguinal region is excluded, decreasing the volume of irradiated normal tissue. For the external iliac region and the cranial border of the CTVe, we agreed on specifying two different recommendations, both considered acceptable. One of these recommendations is novel and risk-adapted; the external iliac region is omitted for low-risk patients, and several different cranial borders are used depending on the individual level of risk.Conclusion: We present NOAC consensus guidelines for delineation of the CTVe in anal cancer, including a risk-adapted strategy.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Undseth, ChristineOslo Univ Hosp, Dept Oncol, Oslo, Norway.,Department of Oncology, Oslo University Hospital, Oslo, Norway (author)
  • Albertsson, PerSahlgrens Univ Hosp, Dept Oncol, Gothenburg, Region Vastra G, Sweden.;Univ Gothenburg, Inst Clin Sci, Sahlgrenska Acad, Dept Oncol, Gothenburg, Sweden.,Sahlgrenska University Hospital, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Region Västra Götaland, Gothenburg, Sweden (author)
  • Eidem, MonikaTrondheim Reg & Univ Hosp, St Olavs Hosp, Canc Clin, Trondheim, Norway.,Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Norway (author)
  • Havelund, Birgitte MaylandLillebaelt Hosp, Univ Hosp Southern Denmark, Dept Oncol, Vejle, Denmark.,Department of Oncology, University Hospital of Southern Denmark, Lillebaelt Hospital, Vejle, Denmark (author)
  • Johannsson, JakobLandspitali Univ Hosp, Dept Radiat Oncol, Reykjavik, Iceland.,Department of Radiation Oncology, Landspitali University Hospital, Reykjavik, Iceland,National University Hospital of Iceland (author)
  • Johnsson, AndersLund University,Lunds universitet,Terapeutisk patologi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Therapeutic pathology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Skåne University Hospital(Swepub:lu)onk-ajo (author)
  • Radu, Calin,1969-Uppsala University,Uppsala universitet,Cancerprecisionsmedicin,Department of Immunology, Genetics and Pathology, Uppsala University, Sweden(Swepub:uu)calra471 (author)
  • Serup-Hansen, EvaCopenhagen Univ Hosp Herlev & Gentofte, Dept Oncol, Copenhagen, Denmark.,Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark (author)
  • Spindler, Karen-LiseAarhus Univ Hosp, Dept Oncol, Aarhus, Denmark.,Department of Oncology, Aarhus University Hospital, Aarhus, Denmark (author)
  • Zackrisson, BjörnUmeå University,Umeå universitet,Onkologi,Umeå Univ, Dept Radiat Sci Oncol, Umeå, Sweden.(Swepub:umu)bjza0002 (author)
  • Guren, Marianne G.Oslo Univ Hosp, Dept Oncol, Oslo, Norway.;Univ Oslo, Inst Clin Med, Oslo, Norway.,Department of Oncology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway (author)
  • Kronborg, CamillaAarhus Univ Hosp, Ctr Particle Therapy, Danish, Aarhus, Denmark.;Aarhus Univ, Dept Clin Med, Aarhus, Denmark.,Centre for Particle Therapy, Aarhus University Hospital, Denmark. Department of Clinical Medicine, Aarhus University, Aarhus, Denmark (author)
  • Lund Univ, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden.;Skane Univ Hosp, Dept Hematol Oncol & Radiat Phys, Lund, Sweden.Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden (creator_code:org_t)

Related titles

  • In:Acta Oncologica: Taylor & Francis62:8, s. 897-9060284-186X1651-226X

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view